Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast calculations
1.3.1 COVID-19 impact calculations on industry forecast
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
Chapter 2 Executive Summary
2.1 Global alpha lipoic acid industry 360° synopsis, 2016 - 2027
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 Region trends
Chapter 3 Alpha Lipoic Acid Industry Insights
3.1 Industry segmentation
3.2 Industry size and forecast, 2016 – 2027
3.2.1 COVID-19 impact on industry size
3.3 Industry ecosystem analysis
3.3.1 Vendor matrix
3.3.2 Distribution channel analysis
3.3.2.1 COVID-19 disruption on distribution channel
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Improving health standards in Asia Pacific
3.4.1.2 Robust product demand for medical applications in North America
3.4.2 Industry pitfalls & challenges
3.4.2.1 Limited product use due to its side effects
3.4.2.2 Availability of several product substitutes
3.5 Regulatory trends
3.5.1 U.S.
3.5.2 Europe
3.5.3 China
3.6 Growth potential analysis, 2020
3.7 Porter’s analysis
3.7.1 Supplier’s power
3.7.2 Buyer power
3.7.3 Threat of new entrant
3.7.4 Threat of substitute
3.8 Company market share analysis, 2020
3.8.1 Strategy landscape
3.9 PESTEL analysis
3.10 Regional price trends
3.11 COVID-19 impact on alpha lipoic acid demand by application
3.11.1 Dietary supplements
3.11.2 Slimming products
3.11.3 Medical drugs
3.11.4 Others
Chapter 4 Alpha Lipoic Acid Market, By Product
4.1 Alpha lipoic acid market share by product, 2020 & 2027
4.2 R-lipoic acid
4.2.1 Market estimates and forecast, 2016 - 2027
4.2.2 Market estimates and forecast, by region, 2016 - 2027
4.3 S-lipoic acid
4.3.1 Market estimates and forecast, 2016 - 2027
4.3.2 Market estimates and forecast, by region, 2016 - 2027
Chapter 5 Alpha Lipoic Acid Market, By Application
5.1 Global alpha lipoic acid market share by application, 2020 & 2027
5.2 Dietary Supplements
5.2.1 Market estimates and forecast, 2016 - 2027
5.2.2 Market estimates and forecast, by region, 2016 - 2027
5.3 Slimming Products
5.3.1 Market estimates and forecast, 2016 - 2027
5.3.2 Market estimates and forecast, by region, 2016 - 2027
5.4 Medical Drugs
5.4.1 Market estimates and forecast, 2016 - 2027
5.4.2 Market estimates and forecast, by region, 2016 - 2027
5.5 Others
5.5.1 Market estimates and forecast, 2016 - 2027
5.5.2 Market estimates and forecast, by region, 2016 - 2027
Chapter 6 Alpha Lipoic Acid Market, By Region
6.1 Alpha lipoic acid market share by region, 2020 & 2027
6.2 North America
6.2.1 Market estimates and forecast, 2016 - 2027
6.2.2 Market estimates and forecast, by product, 2016 - 2027
6.2.3 Market estimates and forecast, by application, 2016 - 2027
6.2.4 U.S.
6.2.4.1 Market estimates and forecast, 2016 - 2027
6.2.4.2 Market estimates and forecast, by product, 2016 - 2027
6.2.4.3 Market estimates and forecast, by application, 2016 - 2027
6.2.5 Canada
6.2.5.1 Market estimates and forecast, 2016 - 2027
6.2.5.2 Market estimates and forecast, by product, 2016 - 2027
6.2.5.3 Market estimates and forecast, by application, 2016 - 2027
6.3 Europe
6.3.1 Market estimates and forecast, 2016 - 2027
6.3.2 Market estimates and forecast, by product, 2016 - 2027
6.3.3 Market estimates and forecast, by application, 2016 - 2027
6.3.4 UK
6.3.4.1 Market estimates and forecast, 2016 - 2027
6.3.4.2 Market estimates and forecast, by product, 2016 - 2027
6.3.4.3 Market estimates and forecast, by application, 2016 - 2027
6.3.5 Germany
6.3.5.1 Market estimates and forecast, 2016 - 2027
6.3.5.2 Market estimates and forecast, by product, 2016 - 2027
6.3.5.3 Market estimates and forecast, by application, 2016 - 2027
6.3.6 France
6.3.6.1 Market estimates and forecast, 2016 - 2027
6.3.6.2 Market estimates and forecast, by product, 2016 - 2027
6.3.6.3 Market estimates and forecast, by application, 2016 - 2027
6.3.7 Spain
6.3.7.1 Market estimates and forecast, 2016 - 2027
6.3.7.2 Market estimates and forecast, by product, 2016 - 2027
6.3.7.3 Market estimates and forecast, by application, 2016 - 2027
6.3.8 Italy
6.3.8.1 Market estimates and forecast, 2016 - 2027
6.3.8.2 Market estimates and forecast, by product, 2016 - 2027
6.3.8.3 Market estimates and forecast, by application, 2016 - 2027
6.4 Asia Pacific
6.4.1 Market estimates and forecast, 2016 - 2027
6.4.2 Market estimates and forecast, by product, 2016 - 2027
6.4.3 Market estimates and forecast, by application, 2016 - 2027
6.4.4 China
6.4.4.1 Market estimates and forecast, 2016 - 2027
6.4.4.2 Market estimates and forecast, by product, 2016 - 2027
6.4.4.3 Market estimates and forecast, by application, 2016 - 2027
6.4.5 Japan
6.4.5.1 Market estimates and forecast, 2016 - 2027
6.4.5.2 Market estimates and forecast, by product, 2016 - 2027
6.4.5.3 Market estimates and forecast, by application, 2016 - 2027
6.4.6 India
6.4.6.1 Market estimates and forecast, 2016 - 2027
6.4.6.2 Market estimates and forecast, by product, 2016 - 2027
6.4.6.3 Market estimates and forecast, by application, 2016 - 2027
6.4.7 Australia
6.4.7.1 Market estimates and forecast, 2016 - 2027
6.4.7.2 Market estimates and forecast, by product, 2016 - 2027
6.4.7.3 Market estimates and forecast, by application, 2016 - 2027
6.4.8 Indonesia
6.4.8.1 Market estimates and forecast, 2016 - 2027
6.4.8.2 Market estimates and forecast, by product, 2016 - 2027
6.4.8.3 Market estimates and forecast, by application, 2016 - 2027
6.4.9 Thailand
6.4.9.1 Market estimates and forecast, 2016 - 2027
6.4.9.2 Market estimates and forecast, by product, 2016 - 2027
6.4.9.3 Market estimates and forecast, by application, 2016 - 2027
6.4.10 Malaysia
6.4.10.1 Market estimates and forecast, 2016 - 2027
6.4.10.2 Market estimates and forecast, by product, 2016 - 2027
6.4.10.3 Market estimates and forecast, by application, 2016 - 2027
6.5 Latin America
6.5.1 Market estimates and forecast, 2016 - 2027
6.5.2 Market estimates and forecast, by product, 2016 - 2027
6.5.3 Market estimates and forecast, by application, 2016 - 2027
6.5.4 Brazil
6.5.4.1 Market estimates and forecast, 2016 - 2027
6.5.4.2 Market estimates and forecast, by product, 2016 - 2027
6.5.4.3 Market estimates and forecast, by application, 2016 - 2027
6.5.5 Mexico
6.5.5.1 Market estimates and forecast, 2016 - 2027
6.5.5.2 Market estimates and forecast, by product, 2016 - 2027
6.5.5.3 Market estimates and forecast, by application, 2016 - 2027
6.6 Middle East & Africa
6.6.1 Market estimates and forecast, 2016 - 2027
6.6.2 Market estimates and forecast, by product, 2016 - 2027
6.6.3 Market estimates and forecast, by application, 2016 - 2027
6.6.4 Saudi Arabia
6.6.4.1 Market estimates and forecast, 2016 - 2027
6.6.4.2 Market estimates and forecast, by product, 2016 - 2027
6.6.4.3 Market estimates and forecast, by application, 2016 - 2027
6.6.5 UAE
6.6.5.1 Market estimates and forecast, 2016 - 2027
6.6.5.2 Market estimates and forecast, by product, 2016 - 2027
6.6.5.3 Market estimates and forecast, by application, 2016 - 2027
6.6.6 South Africa
6.6.6.1 Market estimates and forecast, 2016 - 2027
6.6.6.2 Market estimates and forecast, by product, 2016 - 2027
6.6.6.3 Market estimates and forecast, by application, 2016 - 2027
Chapter 7 Company Profiles
7.1 Infa Group (Olon S.p.A.)
7.1.1 Business Overview
7.1.2 Financial Data
7.1.3 Product Landscape
7.1.4 Strategic Outlook
7.1.5 SWOT Analysis
7.2 Suzhou Fushilai Pharmaceutical Co., Ltd.
7.2.1 Business Overview
7.2.2 Financial Data
7.2.3 Product Landscape
7.2.4 SWOT Analysis
7.3 MTC Industries, Inc.
7.3.1 Business Overview
7.3.2 Financial Data
7.3.3 Product Landscape
7.3.4 Strategic Outlook
7.3.5 SWOT Analysis
7.4 Qufu Maidesen Fine Chemical Co., Ltd.
7.4.1 Business Overview
7.4.2 Financial Data
7.4.3 Product Landscape
7.4.4 SWOT Analysis
7.5 Shandong Qidu Pharmaceutical Co., Ltd.
7.5.1 Business Overview
7.5.2 Financial Data
7.5.3 Product Landscape
7.5.4 SWOT Analysis
7.6 Shanghai Shyndec (Modern) Pharmaceutical Co., Ltd.
7.6.1 Business Overview
7.6.2 Financial Data
7.6.3 Product Landscape
7.6.4 Strategic Outlook
7.6.5 SWOT Analysis
7.7 Jiangsu Tohope Pharmaceutical Co., Ltd.
7.7.1 Business Overview
7.7.2 Financial Data
7.7.3 Product Landscape
7.7.4 SWOT Analysis
7.8 GeroNova Research, Inc.
7.8.1 Business Overview
7.8.2 Financial Data
7.8.3 Product Landscape
7.8.4 SWOT Analysis
7.9 Source Naturals, Inc.
7.9.1 Business Overview
7.9.2 Financial Data
7.9.3 Product Landscape
7.9.4 SWOT Analysis
7.10 HiMedia Laboratories Pvt., Ltd.
7.10.1 Business Overview
7.10.2 Financial Data
7.10.3 Product Landscape
7.10.4 Strategic Outlook
7.10.5 SWOT Analysis
7.11 AlzChem AG
7.11.1 Business Overview
7.11.2 Financial Data
7.11.3 Product Landscape
7.11.4 SWOT Analysis
7.12 Sabinsa Corporation
7.12.1 Business Overview
7.12.2 Financial Data
7.12.3 Product Landscape
7.12.4 Strategic Outlook
7.12.5 SWOT Analysis
7.13 Now Health Group, Inc.
7.13.1 Business Overview
7.13.2 Financial Data
7.13.3 Product Landscape
7.13.4 Strategic Outlook
7.13.5 SWOT Analysis
7.14 Life Extension, Inc.
7.14.1 Business Overview
7.14.2 Financial Data
7.14.3 Product Landscape
7.14.4 SWOT Analysis
7.15 Swanson Health Products, Inc.
7.15.1 Business Overview
7.15.2 Financial Data
7.15.3 Product Landscape
7.15.4 SWOT Analysis
7.16 Cambridge Commodities, Ltd.
7.16.1 Business Overview
7.16.2 Financial Data
7.16.3 Product Landscape
7.16.4 SWOT Analysis
7.17 Toyo Hakko, Co., Ltd.
7.17.1 Business Overview
7.17.2 Financial Data
7.17.3 Product Landscape
7.17.4 SWOT Analysis
